{"id":93899,"date":"2021-03-29T08:16:52","date_gmt":"2021-03-29T08:16:52","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=93899"},"modified":"2023-09-29T05:58:19","modified_gmt":"2023-09-29T05:58:19","slug":"myelomatosis","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/","title":{"rendered":"Myelomatosis"},"content":{"rendered":"<p>A disease where malignant tumours infiltrate the bone marrow.<\/p>\n<hr \/>\n<p>A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.<\/p>\n<hr \/>\n<div class=\"group w-full text-token-text-primary border-b border-black\/10 gizmo:border-0 dark:border-gray-900\/50 gizmo:dark:border-0 bg-gray-50 gizmo:bg-transparent dark:bg-[#444654] gizmo:dark:bg-transparent sm:AIPRM__conversation__response\" data-testid=\"conversation-turn-45\">\n<div class=\"p-4 justify-center text-base md:gap-6 md:py-6 m-auto\">\n<div class=\"flex flex-1 gap-4 text-base mx-auto md:gap-6 gizmo:gap-3 gizmo:md:px-5 gizmo:lg:px-1 gizmo:xl:px-5 md:max-w-2xl lg:max-w-[38rem] gizmo:md:max-w-3xl gizmo:lg:max-w-[40rem] gizmo:xl:max-w-[48rem] xl:max-w-3xl }\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 gizmo:w-full md:gap-3 lg:w-[calc(100%-115px)] agent-turn\">\n<div class=\"flex flex-grow flex-col gap-3 max-w-full\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-3 overflow-x-auto whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler&#8217;s disease, or plasmacytoma.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A disease where malignant tumours infiltrate the bone marrow. A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-93899","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Myelomatosis - Definition of Myelomatosis<\/title>\n<meta name=\"description\" content=\"A disease where malignant tumours infiltrate the bone marrow.A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler&#039;s disease, or plasmacytoma.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myelomatosis - Definition of Myelomatosis\" \/>\n<meta property=\"og:description\" content=\"A disease where malignant tumours infiltrate the bone marrow.A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler&#039;s disease, or plasmacytoma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-29T08:16:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-29T05:58:19+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/\",\"name\":\"Myelomatosis - Definition of Myelomatosis\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-03-29T08:16:52+00:00\",\"dateModified\":\"2023-09-29T05:58:19+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A disease where malignant tumours infiltrate the bone marrow.A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler's disease, or plasmacytoma.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myelomatosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myelomatosis - Definition of Myelomatosis","description":"A disease where malignant tumours infiltrate the bone marrow.A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler's disease, or plasmacytoma.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/","og_locale":"en_US","og_type":"article","og_title":"Myelomatosis - Definition of Myelomatosis","og_description":"A disease where malignant tumours infiltrate the bone marrow.A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler's disease, or plasmacytoma.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/","og_site_name":"Glossary","article_published_time":"2021-03-29T08:16:52+00:00","article_modified_time":"2023-09-29T05:58:19+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/","name":"Myelomatosis - Definition of Myelomatosis","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-03-29T08:16:52+00:00","dateModified":"2023-09-29T05:58:19+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A disease where malignant tumours infiltrate the bone marrow.A malignant disorder of plasma cells, derived from B-lymphocytes. In most patients the bone marrow is heavily infiltrated with atypical, monoclonal plasma cells, which gradually replace the normal cell lines, inducing anaemia, leucopenia, and thrombocytopenia. Bone absorption occurs, producing diffuse osteoporosis. In some cases only part of the immunoglobulin molecule is produced by the tumour cells, appearing in the urine as Bence Jones proteinuria.An extremely rare and lethal condition with an unknown cause, marked by the growth of numerous tumors in the skeleton that originate from the bone marrow. The most commonly affected bones are, in order: spine, ribs, sternum, skull, scapula, pelvis, clavicle, humerus, and femur. Typically, patients succumb within six months from when symptoms begin, though some have lived for one to two years. This disease is also known as hematogenous myeloma, Kahler's disease, or plasmacytoma.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelomatosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Myelomatosis"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/93899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=93899"}],"version-history":[{"count":4,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/93899\/revisions"}],"predecessor-version":[{"id":243322,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/93899\/revisions\/243322"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=93899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=93899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=93899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}